UBS Group
CELUW

UBS Group’s Celularity Inc CELUW Stock Holding History

UBS Group’s Portfolio CELUW Stock Details CELUW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21 Buy
5,278
+3,063
+138% +$21 ﹤0.01% 10269
2026
Q1 		$22 Buy
2,215
+302
+16% +$3 ﹤0.01% 10279
2025
Q4 		$31 Buy
1,913
+600
+46% +$15 ﹤0.01% 10315
2025
Q3 		$46 Buy
+1,313
New +$64 ﹤0.01% 10035
2024
Q4 		– Sell
-168
Closed -$2 – 9964
2024
Q3 		$2 Buy
168
+68
+68% +$1 ﹤0.01% 9409
2024
Q2 		$2 Buy
+100
New +$3 ﹤0.01% 9417
2024
Q1 		– Sell
-38,556
Closed -$1.54K – 9383
2023
Q4 		$1.54K Buy
+38,556
New +$663 ﹤0.01% 8280
2023
Q1 		– Sell
-18,446
Closed -$1.29K – 9655
2022
Q4 		$1.29K Buy
18,446
+18,438
+230,475% +$4.04K ﹤0.01% 9903
2022
Q3 		$0 Hold
8
– – ﹤0.01% 10385
2022
Q2 		$0 Sell
8
-3,566
-100% -$3.51K ﹤0.01% 10367
2022
Q1 		$5K Buy
3,574
+3,566
+44,575% +$2.9K ﹤0.01% 9104
2021
Q4 		$0 Hold
8
– – ﹤0.01% 10282
2021
Q3 		$0 Hold
8
– – ﹤0.01% 9580
2021
Q2 		$0 Buy
+8
New +$10 ﹤0.01% 9410
2021
Q1 		– Sell
-3,067
Closed -$9K – 9025
2020
Q4 		$9K Buy
+3,067
New +$5.75K ﹤0.01% 7552

Other funds holding CELUW

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $48.6B AUM 40.56% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
LOAME
Lombard Odier Asset Management (Europe) London, United Kingdom $2.37B AUM 28.81% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $72.2B AUM 27.85% 1-Year Est. Return
WCM
Weaver Capital Management Suwanee, Georgia $454M AUM 20.18% 1-Year Est. Return

UBS Group's CELUW Position: Q2 2026 in Review

UBS Group increased its Celularity Inc (CELUW) stake by 138% in Q2 2026, buying an estimated $21 and bringing the position to 5,278 shares worth $21. The position accounts for ﹤0.01% of the portfolio, ranked #10269.

UBS Group first reported a position in CELUW in Q4 2020 and has held it in 15 quarters since. The position peaked at $9K in Q4 2020. 16 funds tracked by Wall St. Rank hold CELUW as of Q2 2026.

  • UBS Group held 5,278 shares of Celularity Inc worth $21 as of Q2 2026.
  • UBS Group bought 3,063 Celularity Inc shares in Q2 2026, an estimated $21.
  • Celularity Inc made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10269 holding.
  • UBS Group first reported a position in Celularity Inc in Q4 2020 and has held it in 15 quarters since.
  • UBS Group's Celularity Inc position peaked at $9K in Q4 2020.
  • 16 funds tracked by Wall St. Rank held Celularity Inc as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.